Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec;2(4):239-48.
doi: 10.1055/s-0032-1315454. Epub 2012 Oct 9.

Improving the clinical evidence of bone graft substitute technology in lumbar spine surgery

Affiliations
Review

Improving the clinical evidence of bone graft substitute technology in lumbar spine surgery

Wellington K Hsu et al. Global Spine J. 2012 Dec.

Abstract

Bone graft substitutes have been used routinely for spine fusion for decades, yet clinical evidence establishing comparative data remains sparse. With recent scrutiny paid to the outcomes, complications, and costs associated with osteobiologics, a need to improve available data guiding efficacious use exists. We review the currently available clinical literature, studying the outcomes of various biologics in posterolateral lumbar spine fusion, and establish the need for a multicenter, independent osteobiologics registry.

Keywords: autograft; biologics; bone graft substitute; bone morphogenetic protein; ceramics; demineralized bone matrix; osteobiologics; spine fusion.

PubMed Disclaimer

Conflict of interest statement

Disclosures W. K. Hsu, Consulting: Stryker, Pioneer, Medtronic, Zimmer, Graftys; Research Support: Baxter, Pioneer M. S. Nickoli, None J. C. Wang, Royalties: Medtronics, Stryker, Seaspine, Osprey, Aesculap, Biomet, Amedica, Zimmer, Synthes; Stock Ownership: Fziomed; Private Investments: Promethean Spine, Paradigm Spine, Benevenue, NexGen, K2 Medical, Pioneer, Amedica, Vertiflex, Electrocore, Surgitech, Axiomed; Board of Directors: North American Spine Society, Cervical Spine Research Society, AO Spine/AO Foundation; Scientific Advisory Board: VG Innovations, Corespine, Expanding Orthopaedics, Syndicom, Osprey, Amedica, Bone Biologics, Curative Biosciences, PearlDiver, Inc., Pioneer, Seaspine J. R. Lieberman, Research Support: Amgen, Inc., NIH; Advisory Board, Amgen, Inc. H. S. An, Consulting: Advanced Biologics, Inc., Pioneer, Inc.; Research support: Baxter, Inc. S. T. Yoon, None J. A. Youssef, Consultant: NuVasive, Integra; Royalty: NuVasive, Aesculap/B. Braun, Osprey, Amedica; Research Support: DePuy, Stryker, NuVasive, BioSurface Engineering Technologies, Globus Medical, Advanced Technologies in Regenerative Medicine, Axial Biotech, Vertiflex; Stock Options: Amedica, Pioneer, Vertiflex, Benvenue Medical, Inc., Paradigm Spine, Promethean Surgical Devices, Spinal Ventures D. S. Brodke, None C. M. McCullough, None

Similar articles

Cited by

References

    1. Ludwig S C, Kowalski J M, Boden S D. Osteoinductive bone graft substitutes. Eur Spine J. 2000;9 01:S119–S125. - PMC - PubMed
    1. Carragee E J, Hurwitz E L, Weiner B K. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011;11:471–491. - PubMed
    1. Hall E J, Brenner D J. Cancer risks from diagnostic radiology. Br J Radiol. 2008;81:362–378. - PubMed
    1. An H S, Lynch K, Toth J. Prospective comparison of autograft vs. allograft for adult posterolateral lumbar spine fusion: differences among freeze-dried, frozen, and mixed grafts. J Spinal Disord. 1995;8:131–135. - PubMed
    1. Jorgenson S S, Lowe T G, France J, Sabin J. A prospective analysis of autograft versus allograft in posterolateral lumbar fusion in the same patient. A minimum of 1-year follow-up in 144 patients. Spine. 1994;19:2048–2053. - PubMed

LinkOut - more resources